|
BK2021020605
CAS |
|
Oil dispersible upconverting nanoparticles （UV light）
|
￥Member visible
|
|
|
BK2021020604
CAS |
|
PEG-COOH modified upconverting nanoparticles (UV light)
|
￥Member visible
|
|
|
BK2021020603
CAS |
|
PEG-COOH modified upconverting nanoparticles (green light)
|
￥Member visible
|
|
|
BK2021020602
CAS |
|
PEG-NH2 modified upconverting nanoparticles (UV light)
|
￥Member visible
|
|
|
BK2021020601
CAS |
|
PEG-NH2 modified upconverting nanoparticles (green light)
|
￥Member visible
|
|
CQDs
N/A |
|
Carbon quantum dots
|
￥Member visible
|
|
|
CQDs
N/A |
|
C QDs
|
￥Member visible
|
|
|
PVK-CsPb(Cl/Br)3
N/A |
|
All-Inorganic Perovskite QDs-wavelength
|
￥Member visible
|
|
|
PVK-CsPbCl3
N/A |
|
All-Inorganic Perovskite QDs-component
|
￥Member visible
|
|
SN-NJ-R028
N/A |
|
Quaternary ammonium chitosan composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R029
N/A |
|
Composite hydrogel containing mizoribine nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R030
N/A |
|
Fluorouracil temperature sensitive in situ gel
|
￥Member visible
|
|
|
SN-NJ-R031
N/A |
|
Wound repair chitosan-based composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R032
N/A |
|
Composite hydrogel containing leflunomide nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R033
N/A |
|
Composite hydrogel containing T cell stimulation nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R034
N/A |
|
PLGA nanoparticle composite hydrogel containing activating immunity
|
￥Member visible
|
|
|
SN-NJ-R035
N/A |
|
Nucleic acid vaccine nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R036
N/A |
|
Antigen-containing nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R037
N/A |
|
Compound hydrogel containing immune-enhancing nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R038
N/A |
|
Toxin-containing protein nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R039
N/A |
|
Composite hydrogel containing cyclosporin nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R040
N/A |
|
Composite hydrogel containing cyclophosphamide nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R041
N/A |
|
Composite hydrogel containing mizoribine nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R042
N/A |
|
PLGA nanoparticle composite hydrogel containing rapamycin
|
￥Member visible
|
|
|
SN-NJ-R024
N/A |
|
DC cell immune enhancement adjuvant nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R025
N/A |
|
Temperature sensitive hydrogel
|
￥Member visible
|
|
|
SN-NJ-R026
N/A |
|
PLGA-PEG-PLGA warm water gel
|
￥Member visible
|
|
|
SN-NJ-R027
N/A |
|
Composite hydrogel containing methylprednisolone nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R023
N/A |
|
PLCA-PEG temperature-sensitive hydrogel with OVA plasmid
|
￥Member visible
|
|
|
SN-NJ-R022
N/A |
|
PLCA-HA long-acting immune hydrogel
|
￥Member visible
|
|
|
SN-NJ-R021
N/A |
|
GM-CSF immunoenhancing hydrogel
|
￥Member visible
|
|
|
SN-NP-R50
N/A |
|
Nucleic acid vaccine vesicle compound hydrogel
|
￥Member visible
|
